Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer

Frank A. Sinicrope

Department of Oncology, Mayo Clinic, Rochester, MN

Fang-Shu Ou

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Dirk Arnold

Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg, Germany

Walter R. Peters

Baylor University Medical Center, Dallas

Robert J. Behrens

Iowa-Wide Oncology Research Coalition National Cancer Institute Community Oncology Research Program, Des Moines

Christopher H. Lieu

Division of Medical Oncology, University of Colorado Cancer Center, Aurora

Khalid Matin

Division of Hematology and Oncology, Virginia Commonwealth University, Richmond

Deirdre J. Cohen

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

Samara L. Potter

Nationwide Children’s Hospital, Columbus, OH

Andrew B. Nixon

Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC

Lisa A Kottschade

Department of Oncology, Mayo Clinic, Rochester, MN

Emily Kathol

Nebraska Medicine, Omaha

Wendy L. Frankel

Department of Pathology, Ohio State University Wexner Medical Center, Columbus

Ardaman Shergill

Alliance for Clinical Trials in Oncology, Chicago

Dennis Hsu

University of Pittsburgh Medical Center, Pittsburgh

Anke Reinacher-Schick

Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany

Paul Mehan

Missouri Baptist Medical Center, St. Louis

Philip J. Gold

Swedish Medical Center–First Hill, Seattle

Maged F. Khalil

Lehigh Valley Hospital–Cedar Crest, Allentown, PA

Tyler Zemla

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Clare Gatten

Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN

Eileen M. O’Reilly

Jeffrey A. Meyerhardt